Orlando Bolusan
About Orlando Bolusan
Orlando Bolusan is an Immunotherapy and Cell Culture Specialist at Kite Pharma, where he has worked since 2016. He holds a Bachelor's degree in Zoology and Biology from Far Eastern University and has extensive experience in various research and analytical roles across multiple institutions.
Work at Kite Pharma
Orlando Bolusan has been employed at Kite Pharma since 2016, serving as an Immunotherapy/Cell Culture Specialist. His role focuses on developing and optimizing cell culture processes for immunotherapy applications. Located in Santa Monica, California, he has contributed to the company's efforts in advancing cell-based therapies for cancer treatment over the past eight years.
Education and Expertise
Orlando Bolusan earned a Bachelor's degree in Zoology and Biology from Far Eastern University, where he studied from 1981 to 1985. His educational background provides a strong foundation in biological sciences, which is essential for his work in immunotherapy and cell culture. This expertise is reflected in his professional roles, where he applies his knowledge to complex scientific challenges.
Professional Background
Orlando Bolusan has a diverse professional background in the field of chemistry and research. Before joining Kite Pharma, he worked at the University of California, Los Angeles (UCLA) as a Chemist/Instrument Analyst from 2015 to 2016 and as a Chemist from 1992 to 1997. He also served as a Staff Research Associate at the University of Southern California Atherosclerosis Research Unit from 1997 to 2001. His career includes a significant tenure as a RadioChemist at Eckert & Ziegler Isotope Products, Inc. from 2001 to 2015.
Career Progression
Orlando Bolusan's career has progressed through various roles in research and chemistry. His experience spans over two decades, with positions that have included analytical and research responsibilities. His time at UCLA and the University of Southern California has equipped him with valuable skills in scientific analysis and research methodologies, which he has carried into his current role at Kite Pharma.